Background: Osteoarthritis (OA) is a degenerative joint disease, characterized by cartilage degradation and inflammation. The proinflammatory cytokine, interleukin (IL)-1β, plays a crucial role in the pathogenesis of OA by inducing the release of other catabolic factors that contribute to cartilage degradation. Trifolium pratense L. (red clover) has been used as a medicinal plant in many countries and as a source of nutraceuticals to alleviate the symptoms of menopause. Ob-jectives: In this study, we aimed to evaluate the anticatabolic effect of 40% prethanol extract of T. pratense (40% PeTP) on IL-1β-stimulated chondrocytes. Methods: Primary rat chondrocytes were pretreated with 40% PeTP for 1 h before stimulation with IL-1β (20 ng/mL). The production of nitrite, prostaglandin E2 (PGE2), and aggrecan was measured by using Griess reagent and ELISA. Protein expression of inducible nitric oxide synthase (iNOS), cyclooxygenase (COX)-2, matrix metalloproteinase (MMP)-1, MMP-3, MMP-13, A disintegrin and metalloproteinase with thrombospondin motif (ADAMTS)-4, mitogen-activated protein kinase (MAPK), and the nuclear factor (NF)-κB p65 subunit was measured by using Western blotting. Results: PeTP (40%) significantly inhibited the IL-1β-induced expression of nitrite, iNOS, PGE2, COX-2, MMP-1, MMP-3, MMP-13, and ADAMTS-4 in isolated primary rat chondrocytes. Furthermore, 40% PeTP decreased the IL-1β-induced degradation of aggrecan, the phosphorylation of MAPKs, and the nuclear translocation of the NF-κB p65 subunit. Conclusion: These results suggested that 40% PeTP has a chondroprotective effect on inflammation and may be a potential preventative agent for OA progression.

Keywords:
Osteoarthritis, Trifolium pratense, Chondroprotective effect, Interleukin-1β
1.
Akhtar, N., T.M. Haqqi (2012) Current nutraceuticals in the management of osteoarthritis: a review. Ther Adv Musculoskelet Dis 4: 181–207.
2.
Berenbaum, F. (2004) Signaling transduction: target in osteoarthritis. Curr Opin Rheumatol 16: 616–622.
3.
Blom, A.B., P.M. van der Kraan, W.B. van den Berg (2007) Cytokine targeting in osteoarthritis. Curr Drug Targets 8: 283–292.
4.
Burrage, P.S., K.S. Mix, C.E. Brinckerhoff (2006) Matrix metalloproteinases: role in arthritis. Front Biosci 11: 529–543.
5.
Claassen, H., V. Bries, F. Manapov, B. Nebe, M. Schunke, B. Kurz (2008) The phytoestrogens daidzein and genistein enhance the insulin-stimulated sulfate uptake in articular chondrocytes. Cell Tissues Res 333: 71–79.
6.
Dieppe, P., J. Chard, A. Faulkner, S. Lohmander (1999) Osteoarthritis; in Godlee, F. (ed): Clinical Evidence. London, BMJ Publishing Group, vol 2, pp 437–447.
7.
Felson, D.T., R.C. Lawrence, M.C. Hochberg, T. McAlindon, P.A. Dieppe, M.A. Minor, et al. (2000) Osteoarthritis: new insights. Part 2: treatment approaches. Ann Intern Med 133: 726–737.
8.
Gartoulla, P., M.M. Han (2014) Red clover extract for alleviating hot flushes in postmenopausal women: A meta-analysis. Maturitas 79: 58–64.
9.
Goldring, M.B. (2000) The role of the chondrocyte in osteoarthritis. Arthritis Rheum 43: 1916–1926.
10.
Goldring, S.R., M.B. Goldring (2004) The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 427: S27–S36.
11.
Goldring, M.B., M. Otero, D.A. Plumb, C. Dragomir, M. Favero, K. El Hachem, et al. (2011) Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis. Eur Cell Mater 21: 202–220.
12.
Heinegard, D., T. Saxne (2011) The role of the cartilage matrix in osteoarthritis. Nat Rev Rheumatol 7: 50–56.
13.
Hochberg, M.C., R.D. Altman, K.T. April, M. Benkhalti, G. Guyatt, J. McGowan, et al. (2012) American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 64: 465–474.
14.
Hosseinzadeh, A., K. Bahrampour Juybari, M.J. Fatemi, T. Kamarul, A. Bagheri, N. Tekiyehmaroof, et al. (2017) Protective effect of ginger (Zingiber officinale Roscoe) extract against oxidative stress and mitochondrial apoptosis induced by interleukin-1β in cultured chondrocytes. Cells Tissues Organs 204: 241–250.
15.
Howes, J.B., L.G. Howes (2002) Content of isoflavone-containing preparations. Med J Aust 176: 135–136.
16.
Hu, Z.C., L.F. Gong, X.B. Li, X. Fu, J.W. Xuan, Z.H. Feng, et al. (2018) Inhibition of PI3K/Akt/NF-κB signaling with leonurine for ameliorating the progression of osteoarthritis: in vitro and in vivo studies. J Cell Physiol 2018: 1–11
17.
Jeoun, J.W., H.H. Lee, K.W. Lee, K.Y. Kim, S.G. Kim, S.H. Hong, et al. (2016) Mori folium inhibits interleukin-1β-induced expression of matrix metalloproteinases and inflammatory mediators by suppressing the activation of NF-κB and p38 MAPK in SW1353 human chondrocytes. Int J Mol Med 37: 452–460.
18.
Karsdal M.A., A.C. Bay-Jensen, K. Henriksen, C. Christianse (2012) The pathogenesis of osteoarthritis involves bone, cartilage and synovial inflammation: may estrogen be a magic bullet? Menopause Int 18: 139–146.
19.
Khan, N.M., A. Haseeb, M.Y. Ansari, T.M. Haqqi (2010) A wogonin-rich-fraction of Scutellaria baicalensis root extract exerts chondroprotective effects by suppressing IL-1β-induced activation of AP-1 in human OA chondrocytes. Sci Rep 7: 43789.
20.
Khan, S.W., S. Khatoon (2008) Ethnobotanical studies on some useful herbs of Haramosh and Bugrote Valley in Gilgit, northern areas of Pakistan. Pak J Bot 40: 43–58.
21.
Kim, J.H., J.E. Huh, Y.H. Baek, J.D. Lee, D.Y. Choi, D.S. Park (2011) Effect of Phellodendron amurense in protecting human osteoarthritic cartilage and chondrocytes. J Ethnopharmacol 134: 234–242.
22.
Kobayashi, M., G.R. Squires, A. Mousa, M. Tanzer, D.J. Zukor, J. Antoniou, et al. (2005) Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 52: 128–135.
23.
Kolodziejczyk-Czepas, J. (2012) Trifolium species-derived substances and extracts. Biological activity and prospects for medicinal applications. J Ethnopharmacol 143: 14–23.
24.
Krenn, L., D.H. Pape (2009) Inhibition angiogenesis and inflammation by an extract of red clover (Trifolium pratense L.). Phytomedicine 16: 1083–1088.
25.
Lee, S.A., S.M. Moon, S.H. Han, E.J. Hwang, B.R. Park, J.S. Kim, et al. (2018a) Chondroprotective effects of aqueous extract of Anthriscus sylvestris leaves on osteoarthritis in vitro and in vivo through MAPKs and NF-κB signaling inhibition. Biomed Pharmacother 103: 1202–1211.
26.
Lee, S.A., B.R. Park, S.M. Moon, S.H. Han, C.S. Kim (2018b) Anti-inflammatory potential of Trifolium pratense L. leaf extract in LPS-stimulated RAW2647 cells and in a rat model of carrageenan-induced inflammation. Arch Physiol Biochem 15: 1–8.
27.
Li, N., M.A. Rivera-Bermudez, M. Zhang, J. Tejada, S.S. Glasson, L.A. Collins-Racie, et al. (2010) LXR modulation blocks prostaglandin E2 production and matrix degradation in cartilage and alleviates pain in a rat osteoarthritis model. Proc Natl Acad Sci USA 107: 3734–3739.
28.
Loeser, R.F. (2006) Molecular mechanisms of cartilage destruction: mechanics, inflammatory mediators, and aging collide. Arthritis Rheum 54: 1357–1360.
29.
Loeser, R.F. (2009) Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthr Cartil 17: 971–979.
30.
Ma, C., X. Zhou, K. Xu, L. Wang, Y. Yang, W. Wang, et al. (2018) Specnuezhenide decreases interleukin-1β-induced inflammation in rat chondrocytes and reduces joint destruction in osteoarthritic rats. Front Pharmacol 9: 700.
31.
Majumdar, M.K., R. Askew, S. Schelling, N. Stedman, T. Blanchet, B. Hopkins, et al. (2007) Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis. Arthritis Rheum 56: 3670–3674.
32.
Malemud, C.J., N. Islam, T.M. Haqqi (2003) Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs 174: 34–48.
33.
Maneix, L., A. Servent, B. Poree, D. Ollitrault, T. Branly, N. Bigot, et al. (2014) Up-regulation of type II collagen gene by 17β-estradiol in articular chondrocytes involves Sp1/3, Sox-9, and estreogen receptor alpha. J Mol Med (Berl) 92: 1179–1200.
34.
McAlindon, T.E., R.R. Bannuru, M.C. Sullivan, N.K. Arden, F. Berenbaum, S.M. Bierma- Zeinstra, et al. (2014) OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil 22: 363–388.
35.
Myers, S.P., V. Vigar (2017) Effects of a standardised extract of Trifolium pratense (Promensil) at a dosage of 80 mg in the treatment of menopausal hot flushes: a systematic review and meta-analysis. Phytomedicine 24: 141–147.
36.
Rahman, M.M. (2018) Chondroprotective effects of a standardized extract (KBH-JP-040) from Kalopanax pictus, Hericium erinaceus, and Astragalus membranaceus in experimentally induced in vitro and in vivo osteoarthritis models. Nutrients 10: 356.
37.
Sabudak, T., D. Dokmeci, F. Ozyigit, E. Isik, N. Aydogdu (2008) Anti-inflammatory and antioxidant activities of Trifolium resupinatum var. microcephalum extracts. Asian J Chem 20: 1491–1496.
38.
Sabudak, T., N. Guler (2009) Trifolium L. A review on its phytochemical and pharmacological profile. Phytother Res 23: 439–446.
39.
Sanbongi, C., N. Osakabe, M. Natsume, T. Takizawa, S. Gomi, T. Osawa (1998) Antioxidative polyphenols isolated from Theobroma cacao. J Agric Food Chem 46: 454–457.
40.
Sasaki, K., T. Hattori, T. Fujisawa, K. Takahashi, H. Inoue, M. Takigawa (1998) Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes. J Biochem 123: 431–439.
41.
Schroeppel, J.P., J.D. Crist, H.C. Anderson, J. Wang (2011) Molecular regulation of articular chondrocyte function and its significance in osteoarthritis. Histol Histopathol 26: 377–394.
42.
Seo, S.K., H.I. Yang, K.J. Lim, Y.E. Jeon, Y.S. Choi, S. Cho, et al. (2012) Changes in serum levels of cartilage oligomeric matrix protein after estrogen and alendronate therapy in postmenopausal women. Gynecol Obstet Invest 74: 143–150.
43.
Spector T.D., D. Nandra, D.J. Hart, D.V. Doyle (1997) Is hormone replacement therapy protective for hand and knee osteoarthritis in women? The Chingford Study. Ann Rheum Dis 56: 432–444.
44.
van den Berg, W.B. (2000) Pathophysiology of osteoarthritis. Joint Bone Spine 67: 555–556.
45.
Vincenti, M.P., C.E. Brinckerhoff (2002) Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 4: 157–164.
46.
Vlaisavljevic, S., B. Kaurinovic, M. Popovic, M. Djurendic-Brenesel, B. Vasiljevic, D. Cvetkovic, et al. (2014) Trifolium pratense L. as a potential natural antioxidant. Molecules 19: 713–725.
47.
Wang, M., E.R., Sampson, H. Jin, J. Li, Q.H. Ke, H.J. Im, et al. (2013) MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Res Ther 15: R5.
48.
Wluka, A.E., F.M. Cicuttini, T.D. Spector (2000) Menopause, oestrogens and arthritis. Maturitas 35: 183–199.
49.
Xiao, Y.P., F.M. Tian, M.W. Dai, W.Y. Wang, L.T. Shao, L. Zang (2016) Are estrogen-related drugs new alternatives for the management of osteoarthritis? Arthritis Res Ther 18: 151.
50.
Xie, X.W., R.Z., Wan, Z.P. Liu (2017) Recent research advances in selective matrix metalloproteinase-13 inhibitors as anti-osteoarthritis agents. Chem Med Chem 12: 1157–1168.
51.
Zhang, X., Y. Zhu, X. Chen, Y. Zhang, Y. Zhang, Y. Jia, et al. (2014) Baicalein ameliorates inflammatory-related apoptotic and catabolic phenotypes in human chondrocytes. Int Immunopharmacol 21: 301–308.
52.
Zheng, W., Z. Feng, S. You, H. Zhang, Z. Tao, Q. Wang, H. Chen, Y. Wu (2017) Fisetin inhibits IL-1β-induced inflammatory response in human osteoarthritis chondrocytes through activating SIRT1 and attenuates the progression of osteoarthritis in mice. Int Immunopharmacol 45: 135–147.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.